Ardehaie Reza Mousavi, Eslahi Atieh, Alerasool Masoome, Rad Elham Khani, Shoeibi Nasser, Sedaghat Mohammad Reza, Avan Amir, Pasdar Alireza, Mojarrad Majid
Department of Medical Genetics and Molecular Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Medical Genetic Research Centre, Mashhad University of Medical Sciences, Mashhad, Iran.
Clin Genet. 2025 Mar;107(3):300-310. doi: 10.1111/cge.14662. Epub 2025 Jan 6.
Inherited retinal diseases (IRDs) may have significant diagnostic challenges due to their genetic complexity and diverse inheritance patterns. Advanced genotyping tools like exome sequencing (ES) offer promising opportunities for identifying causative variants and improving disease management. This retrospective study was aimed to present prevalent pathogenic and novel variants in patients diagnosed with IRDs using ES. We investigated 154 patients diagnosed clinically with IRDs, of which non-syndromic IRDs were more prevalent than syndromic form (56% vs. ~44%). Out of 154 unrelated patients, 133 (86%) were genetically resolved, where retinitis pigmentosa was the most common subtype (26% of all resolved patients). Fifty-three previously known and also 56 novel variants across known IRD genes were identified. Autosomal recessive inheritance predominated in both resolved forms (112/133, 84.21%), with 46 novel variants. This could be due to high rate of consanguinity in the studied families (114/133 patients, 85.71%). The two previously reported ancestral founder pathogenic variants in TMEM67 (c.725A > G) and BBS2 (c.471G > A) genes, as well as the most common variant in AIPL1 gene (c.834G > A), were also prevalent in our patients. Interestingly, identical novel compound heterozygote of the CEP290 gene (c.3167C > A and c.7024C > T) were identified in two unrelated cases. This retrospective study was the first attempt in terms of sample size and diversity to add more to our current knowledge of the genetic makeup of IRDs in a population from the East of Iran. Our findings can facilitate genetic counselling and subtype classification of IRDs, especially in challenging cases.
由于遗传复杂性和多样的遗传模式,遗传性视网膜疾病(IRD)可能面临重大的诊断挑战。外显子组测序(ES)等先进的基因分型工具为识别致病变异和改善疾病管理提供了有前景的机会。这项回顾性研究旨在呈现使用ES诊断为IRD的患者中常见的致病和新变异。我们调查了154例临床诊断为IRD的患者,其中非综合征性IRD比综合征性形式更常见(约56%对约44%)。在154例无关患者中,133例(约86%)得到了基因诊断,其中色素性视网膜炎是最常见的亚型(占所有确诊患者的26%)。在已知的IRD基因中鉴定出了53个先前已知的变异以及56个新变异。在两种确诊形式中,常染色体隐性遗传占主导(112/133,84.21%),有46个新变异。这可能是由于研究的家族中近亲结婚率高(114/133例患者,85.71%)。先前报道的TMEM67基因(c.725A>G)和BBS2基因(c.471G>A)中的两个祖传奠基者致病变异,以及AIPL1基因中最常见的变异(c.834G>A),在我们的患者中也很普遍。有趣的是,在两个无关病例中鉴定出了相同的CEP290基因新复合杂合子(c.3167C>A和c.7024C>T)。就样本量和多样性而言,这项回顾性研究是首次尝试,以增加我们目前对伊朗东部人群中IRD基因组成的了解。我们的发现有助于IRD的遗传咨询和亚型分类,特别是在具有挑战性的病例中。